Abraham Bautista-Castillo

Abraham Bautista-Castillo

Auto-generated profile, based on publicly available information

Abraham Bautista-Castillo

Computational Biomedicine Lab, University of Houston, 4349 Martin Luther King Boulevard, Houston, 77204, TX, USA; Department of Biomedical Engineering, University of Houston, 3605 Cullen Boulevard, Houston, 77204, TX, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2025 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
ABAbraham Bautista-Castillo
Abraham Bautista-Castillo
ACAngela Chun
Angela Chun
TVTiphanie P. Vogel
Tiphanie P. Vogel
Ioannis A KakadiarisIoannis A Kakadiaris
Ioannis A Kakadiaris

7 January 2025 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
ACAngela Chun
Angela Chun
ABAbraham Bautista-Castillo
Abraham Bautista-Castillo
IOIsabella Osuna
Isabella Osuna
KNKristiana Nasto
Kristiana Nasto
FMFlor M Munoz
Flor M Munoz
IKIoannis A Kakadiaris
Ioannis A Kakadiaris
Background: The pandemic emergent disease multisystem inflammatory syndrome in children (MIS-C) following coronavirus disease-19 infection can mimic endemic typhus. We aimed to use artificial intelligence (AI) to develop a clinical decision support system that accurately distinguishes MIS-C versus endemic typhus (MET). Methods: Demographic, clinical, and laboratory features rapidly available following presentation were extracted for 133 patients with MIS-C and 87 patients hospitalized due to typhus. An attention module assigned importance to inputs used to create the 2-phase AI-MET. Phase 1 uses 17 features to arrive at a classification manually (MET-17). If the confidence level is not surpassed, 13 additional features are added to calculate MET-30 using a recurrent neural network. Results: While 24 of 30 features differed statistically, the values overlapped sufficiently that the features were clinically irrelevant distinguishers as individual parameters. However, AI-MET successfully classified typhus and MIS-C with 100% accuracy. A validation cohort of 111 additional patients with MIS-C was classified with 99% accuracy. Conclusions: Artificial intelligence can successfully distinguish MIS-C from typhus using rapidly available features. This decision support system will be a valuable tool for front-line providers facing the difficulty of diagnosing a febrile child in endemic areas.

20 June 2023 in medRxiv
Verified
Preprint
Open access
PDF file
ABAbraham Bautista-Castillo
Abraham Bautista-Castillo
ACAngela Christine Chun
Angela Christine Chun
TVTiphanie Phillips Vogel
Tiphanie Phillips Vogel
Ioannis A KakadiarisIoannis A Kakadiaris
Ioannis A Kakadiaris
A bstract: The COVID-19 pandemic brought several diagnostic challenges, including the post-infectious sequelae multisystem inflammatory syndrome in children (MIS-C). Some of the clinical features of this syndrome can be found in other pathologies such as Kawasaki disease, toxic shock syndrome, and endemic typhus. Endemic typhus, or murine typhus, is an acute infection treated much differently than MIS-C, so early detection is crucial to a favorable prognosis for patients with these disorders. Clinical Decision Support Systems (CDSS) are computer systems designed to support the decision-making of medical teams about their patients and intended to improve uprising clinical challenges in healthcare. In this article, we present a CDSS to distinguish between MIS-C and typhus that includes a scoring system that allows the timely distinction of both pathologies only using clinical and laboratory features typically available within the first six hours of presentation to the Emergency Department (ED). The proposed approach was trained and tested on datasets of 87 typhus patients and 133 MIS-C patients. A comparison was made against five well-known statistical and machine-learning models. A second dataset with 111 MIS-C patients was used to verify the AI-MET effectiveness and robustness. The performance assessment for AI-MET and the five statistical and machine learning models was done by computing Sensitivity, Specificity, Accuracy, and Precision. The AI-MET system scores 100 percent in the five metrics used on the training and testing dataset and 99 percent on the validation dataset.